- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | Vivos Therapeutics, Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| Mi | Vivos Therapeutics reports 70% revenue increase in Q1 2026 | 2 | Investing.com | ||
| VIVOS THERAPEUTICS Aktie jetzt für 0€ handeln | |||||
| Mi | Vivos Therapeutics GAAP EPS of -$0.52 misses by $0.07, revenue of $5.14M beats by $0.79M | 2 | Seeking Alpha | ||
| Mi | Vivos Therapeutics, Inc: Vivos Therapeutics Reports First Quarter 2026 Financial Results and Provides Operational Update | 30 | GlobeNewswire (Europe) | Year-over-year revenue increased 70%, reflecting contribution from Vivos' acquisition of The Sleep Center of Nevada Management to Host Conference Call today at 5:00 pm ET LITTLETON, Colo., May 20... ► Artikel lesen | |
| Fr | Vivos Therapeutics, Inc. - NT 10-Q, Notification of inability to timely file Form 10-Q or 10-QSB | 2 | SEC Filings | ||
| 22.04. | Vivos Therapeutics erhält Rüge der NASDAQ wegen Nichteinhaltung der Eigenkapitalanforderung | 1 | Investing.com Deutsch | ||
| 22.04. | Vivos Therapeutics, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 20.04. | H.C. Wainwright senkt Kursziel für Vivos Therapeutics auf 2,50 US-Dollar | 1 | Investing.com Deutsch | ||
| 20.04. | Vivos Therapeutics stock price target lowered to $2.50 by H.C. Wainwright | 1 | Investing.com | ||
| 18.04. | New to The Street to Broadcast Tonight on Bloomberg at 6:30 PM EST - Show #744 Featuring Virtuix Holdings, Neonc Technologies Holdings, Medicus Pharma, YY Group Holding, and Vivos Therapeutics | 781 | ACCESS Newswire | The show also broadcasts as sponsored programming additionally across MENA and Latin America as "Nuevo En La Calle," reaching millions of households worldwide weekly, with expanded digital distribution... ► Artikel lesen | |
| 16.04. | Vivos Therapeutics Inc Full Year Sales Increase | 1 | RTTNews | ||
| 15.04. | Vivos Therapeutics, Inc: Vivos Therapeutics Reports Full Year 2025 Financial Results | 157 | GlobeNewswire (Europe) | Full Year 2025 revenue increased 16% Integration of The Sleep Center of Nevada and shift in business model support path to improved revenues, margins and cash flow Management to Host Conference Call... ► Artikel lesen | |
| 15.04. | Vivos Therapeutics, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 15.04. | Vivos Therapeutics, Inc. - 10-K, Annual Report | - | SEC Filings | ||
| 11.04. | New to The Street to Broadcast on Fox Business on Monday, April 13, Featuring Virtuix Holdings, Medicus Pharma, YY Group Holdings, Vivos Therapeutics, and Stardust Power | 1.627 | ACCESS Newswire | The show will air as sponsored programming nationwide at 10:30 PM PST on Fox Business Network NEW YORK CITY, NY / ACCESS Newswire / April 11, 2026 / New to The Street, one of the longest-running U.S.... ► Artikel lesen | |
| 11.04. | New to The Street Broadcasts on Bloomberg Television at 6:30 PM EST Featuring IGC Pharma, Vivos Therapeutics, Acurx Pharmaceuticals, and Equinox Gold | 1.183 | ACCESS Newswire | Special continuing M&A Segment with Senior M&A Partner at Sullivan & Cromwell LLP, Frank Aquila NEW YORK CITY, NY / ACCESS Newswire / April 11, 2026 / New to The Street announces its latest nationally... ► Artikel lesen | |
| 07.04. | Vivos Therapeutics sichert sich 2,25 Mio. US-Dollar durch Privatplatzierung | 1 | Investing.com Deutsch | ||
| 07.04. | Vivos Therapeutics closes $2.25M private placement with Seneca | 1 | Investing.com | ||
| 07.04. | Vivos Therapeutics, Inc: Vivos Therapeutics Completes Private Placement with Existing Private Equity Investor, New Seneca Partners | 2 | GlobeNewswire (USA) | ||
| 06.04. | Broadcom, Vivos Therapeutics And 3 Stocks To Watch Heading Into Monday | 9 | Benzinga.com |
1 2 3 Weiter >>
43 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ECKERT & ZIEGLER | 15,240 | +1,06 % | Eckert&Ziegler im freien Fall: Was die wenigsten Anleger auf dem Schirm haben - Was ich konkret unternommen habe | ||
| SERNOVA BIOTHERAPEUTICS | 0,094 | +1,95 % | Sernova Biotherapeutics: Sernova Biotherapeutics Announces Closing of Recently Approved Financings | Toronto, Ontario and Boston, Massachusetts--(Newsfile Corp. - April 23, 2026) - Sernova Biotherapeutics (TSX: SVA) (OTC: SEOVF) (FSE: PSHO) (XETRA: PSHO) ("Sernova" or the "Company"), a leading... ► Artikel lesen | |
| SYNLAB | 12,710 | 0,00 % | EQS-News: SYNLAB: Die Region Stockholm beauftragt SYNLAB mit dem Ausbau ihrer medizinischen Diagnostikdienstleistungen in Schweden | EQS-News: SYNLAB
/ Schlagwort(e): Sonstiges
Die Region Stockholm beauftragt SYNLAB mit dem Ausbau ihrer medizinischen Diagnostikdienstleistungen in Schweden
31.03.2026... ► Artikel lesen | |
| NUGEN MEDICAL DEVICES | 0,016 | +13,89 % | NuGen Medical Devices Inc.: NuGen Files Patent for Ready-to-Fill COP/COC Needle-Free Injection Nozzle, Advancing Prefilled Nozzle Technology | Toronto, Ontario--(Newsfile Corp. - March 25, 2026) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen"), a leader in needle-free drug delivery, today announced the filing of a new patent covering... ► Artikel lesen | |
| PLUS THERAPEUTICS | 5,440 | +10,46 % | Plus Therapeutics Inc.: Plus Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update on REYOBIQ Clinical Program and CNSide Commercial Rollout | HOUSTON, May 15, 2026 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) ("Plus" or the "Company"), a healthcare company developing and commercializing precision diagnostics and radiopharmaceuticals... ► Artikel lesen | |
| CARDINAL HEALTH | 172,45 | +0,64 % | Here's Why You Should Add Cardinal Health Stock to Your Portfolio Now | ||
| ATOSSA THERAPEUTICS | 4,040 | -3,81 % | Atossa Therapeutics Inc: Atossa Therapeutics Reports First Quarter 2026 Financial Results and Provides a Corporate Update | SEATTLE, May 8, 2026 /PRNewswire/ -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (Atossa or the Company), a clinical-stage biopharmaceutical company developing novel... ► Artikel lesen | |
| INVITAE | - | - | Patentstreit: Natera sichert sich 30 % Lizenzgebühr von Invitae | ||
| EVOFEM BIOSCIENCES | - | - | Evofem Biosciences, Inc. - 8-K, Current Report | ||
| UNIDOC HEALTH | 0,062 | -9,57 % | UniDoc Health Corp.: UniDoc to Update and Relaunch Legacy eHealth Systems with Pawnee Mental Health Services Across Rural Kansas | Ex-AMD Telemedicine account aims to relaunch utilizing UniDoc Connect-enabled eHealth system VANCOUVER, BC / ACCESS Newswire / May 7, 2026 / UniDoc Health Corp. (CSE:UDOC)(FRA:L7T)(OTCQB:UDOCF) ("UniDoc"... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 58,58 | -0,02 % | BrightSpring Health Services, Inc. Reports First Quarter 2026 Financial Results and Increases Full Year 2026 Guidance | LOUISVILLE, Ky., May 01, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 16,660 | 0,00 % | Medicare Advantage Company Alignment Healthcare Shows Huge, Unusual Call Option Activity | ||
| BILLIONTOONE | 83,22 | -0,19 % | Jim Cramer on BillionToOne: "I Say Buy It" | ||
| PROGYNY | 25,660 | +0,08 % | Canaccord upgrades Progyny stock rating to buy on guidance beat streak | ||
| GENEDX | 44,740 | +0,02 % | GeneDx (WGS) Fell Despite Continued Execution Improvement |
VIVOS THERAPEUTICS INC gehört der Branche Gesundheitswesen an. Der aktuelle Kurs liegt bei 0,590 Euro und damit 0,00 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu VIVOS THERAPEUTICS INC finden Sie auf Wallstreet Online.